Nanomedicine
Volume 17, 2022 - Issue 12
Foreword: Special Focus Issue - Targeted drug delivery for inflammatory lung diseases: Part I
Special Focus Issue on Targeted Drug Delivery for Inflammatory Lung Diseases
Kamal Dua1 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, Australia;2 Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, Sydney, NSW, 2007, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0002-7507-1159View further author information
https://orcid.org/0000-0002-7507-1159View further author information, Raimar Lobenberg3 Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, T6G 2R3, Canadahttps://orcid.org/0000-0002-0919-0213View further author information
https://orcid.org/0000-0002-0919-0213View further author information & Dinesh Kumar Chellappan4 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysiahttps://orcid.org/0000-0001-5567-6663View further author information
https://orcid.org/0000-0001-5567-6663View further author information